Pertinax Pharma Appoints New Chairman

Pertinax Pharma has appointed Nigel Brooksby as chairman. His main responsibilities include assisting in corporate, strategic and business development. This comes after last month’s launch of Pertinax, which has a wide range of potential applications, spanning throughout the wound care, medical device, dental, and veterinary markets.

Brooksby brings nearly four decades of pharmaceutical industry experience, much of that spent in the life sciences arena. He started out medical sales representative and rose to an industry leader.

“We are delighted that Nigel has chosen to join our board. His unparalleled experience in the pharmaceutical and related industries, his long established industry connections and his experience with early stage biomedical companies make him the ideal individual for the tasks at hand.” said Michele Barbour, founder and chief science officer of Pertinax Pharma